Atlas Trials

Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease

Clinical trial NCT02778464 · COMPLETED

Trial details

NCT number
NCT02778464
Sponsor
The Royal Wolverhampton Hospitals NHS Trust
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel Disease (IBD)Crohn's Disease (CD)Ulcerative Colitis (UC)Pregnancy
Start date
2016-11-08
Primary completion
2020-01-31
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.